Skip to main content

Table 3 Number of tumours classified as complete, partial or minor pathological response according to drug regimen

From: The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET

Response

TAX → FEC

FEC → TAX

Total (all women)

cPR

6/31 (19)

8/29 (28)

14/60 (23)

pPR

9/31 (29)

9/29 (31)

18/60 (30)

mPR

16/31 (52)

12/29 (41)

28/60 (47)

  1. Number of tumours classified as a complete pathological response (cPR), partial pathological response (pPR) or minor pathological response (mPR) after completion of neoadjuvant chemotherapy according to drug regimen. Data presented as n/N (%). TAX, docetaxel (Taxotere®); FEC, combined flourouracil-epirubicin-cyclophosphamide anthracycline-based chemotherapy.
Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us